×
Aktivieren Sie Javascript in Ihrem Browser, um unsere Webseite optimal zu nutzen.
RAB17, Member RAS Oncogene Family (RAB17) (N-Term) Peptid
RAB17
Reaktivität: Maus, Human
Wirt: Synthetic
BP, WB
Produktnummer ABIN1541235
150,78 €
Zzgl. Versandkosten 20,00 € und MwSt
Lieferung in 15 bis 22 Werktagen
Kurzübersicht für RAB17, Member RAS Oncogene Family (RAB17) (N-Term) Peptid (ABIN1541235)
Target
RAB17
(RAB17, Member RAS Oncogene Family (RAB17))
Spezies
Maus, Human
Quelle
Alle Wirte für RAB17 Peptide
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB)
Produktdetails
(ausblenden)
Protein Region
N-Term
Sequenz
GSSSLKLEIW DTAGQEKYQS VCHLYFRGAN AALLVYDITR KDSFHKAQQW
Produktmerkmale
This is a synthetic peptide designed for use in combination with anti-Rab17 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Aufreinigung
Purified
Alternativen
(anzeigen)
Anwendungsinformationen
(ausblenden)
Applikationshinweise
Each Investigator should determine their own optimal working dilution for specific applications.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Handhabung
(ausblenden)
Format
Lyophilized
Rekonstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Konzentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Handhabung
Avoid repeated freeze-thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Antigendetails
(ausblenden)
Target
RAB17
(RAB17, Member RAS Oncogene Family (RAB17))
Hintergrund
Rab17 might be involved in transcellular transport. Alias Symbols: AW413472 Protein Size: 214
Molekulargewicht
24 kDa
Gen-ID
19329
NCBI Accession
NM_008998 , NP_033024
UniProt
P35292
Zuletzt angesehen
(ausblenden)
Sie sind hier:
Startseite
RAB17, Member RAS Oncogene Family (RAB17) (N-Term) Peptid (ABIN1541235)
Chat with us , powered by LiveChat